136
Participants
Start Date
April 10, 2021
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2026
Metformin
Patients will begin treatment with metformin administered orally at a starting dose of 425 mg / day every 12 hours for the first 15 days and then continue with a dose of 850 mg / day until the end of the study. The beginning of this treatment phase will be following the recommendations of the clinical guidelines (Comprehensive Approach to Type 2 Diabetes Mellitus, SEEN V2019.2)
RECRUITING
Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
OTHER